AI Model IDs Women With Subjective Cognitive Decline During Menopause
By Lori Solomon HealthDay Reporter
WEDNESDAY, Jan. 22, 2025 -- Machine learning models may be able to identify women with severe subjective cognitive decline (SCD) during the menopause transition, according to a study published online Jan. 14 in Menopause.
Xiangyu Zhao, from Shandong University in Jinan, China, and colleagues developed and validated a machine learning model for identifying individuals experiencing severe SCD during the menopause transition. The analysis included data from 1,264 nurses.
The researchers found that the Bortua algorithm (a feature-selection algorithm) identified 13 significant associated factors. The support vector machine exhibited the best overall performance out of the seven models, achieving an area under the receiver operating characteristic curve of 0.846, accuracy of 0.789, sensitivity of 0.753, specificity of 0.802, and an F1 score of 0.658. Menopausal symptoms and the stage of menopause were the two variables most strongly associated with SCD.
"This study highlights how the use of machine learning can be employed to identify women experiencing severe SCD during the menopause transition and potential associated factors," Stephanie Faubion, M.D., medical director of The Menopause Society, said in a statement. "Early identification of high-risk persons may allow for targeted interventions to protect cognitive health. Future studies involving objective measures of cognition and longitudinal follow-up are crucial to better understanding these associations."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-23 06:00
Read more
- Low Birth Weight May Increase Risk for Later COPD
- Therapeutic-Dose Anticoagulation Linked to Lower Mortality in COVID-19
- Psychedelics May Boost Mental Health of People with Cancer in Recovery
- DoxyPEP Lowers Rate of Sexually Transmitted Infections (STIs), Data Suggests
- Has RSV Vaccine Hesitancy Subsided?
- Access to Medical Test Results Is Confusing, Anxiety-Provoking
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions